000 01580 a2200397 4500
005 20250516013751.0
264 0 _c20110314
008 201103s 0 0 eng d
022 _a1460-2091
024 7 _a10.1093/jac/dkq252
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJones, Ronald N
245 0 0 _aCeftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cNov 2010
300 _aiv17-31 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aCephalosporins
_xpharmacology
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aEurope
650 0 4 _aGram-Negative Bacteria
_xdrug effects
650 0 4 _aGram-Positive Cocci
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMethicillin-Resistant Staphylococcus aureus
_xdrug effects
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aPopulation Surveillance
_xmethods
650 0 4 _aSkin Diseases, Bacterial
_xdrug therapy
650 0 4 _aSoft Tissue Infections
_xdrug therapy
650 0 4 _aTreatment Outcome
650 0 4 _aUnited States
650 0 4 _aCeftaroline
700 1 _aMendes, Rodrigo E
700 1 _aSader, Helio S
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 65 Suppl 4
_gp. iv17-31
856 4 0 _uhttps://doi.org/10.1093/jac/dkq252
_zAvailable from publisher's website
999 _c20408009
_d20408009